EP0337896A1 - Hybridisationssonden zum Nachweis von Neisseria-Stämme - Google Patents

Hybridisationssonden zum Nachweis von Neisseria-Stämme Download PDF

Info

Publication number
EP0337896A1
EP0337896A1 EP89401045A EP89401045A EP0337896A1 EP 0337896 A1 EP0337896 A1 EP 0337896A1 EP 89401045 A EP89401045 A EP 89401045A EP 89401045 A EP89401045 A EP 89401045A EP 0337896 A1 EP0337896 A1 EP 0337896A1
Authority
EP
European Patent Office
Prior art keywords
probes
hybridization
range
probe
anyone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP89401045A
Other languages
English (en)
French (fr)
Other versions
EP0337896B1 (de
Inventor
Rudi Rossau
Hugo Van Heuverswijn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Priority to AT89401045T priority Critical patent/ATE92111T1/de
Publication of EP0337896A1 publication Critical patent/EP0337896A1/de
Application granted granted Critical
Publication of EP0337896B1 publication Critical patent/EP0337896B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays

Definitions

  • the invention relates to hybridization probes for detecting Neisseria strains and isolates belonging to the genus Neisseria and related taxa.
  • strains also encompasses isolates or organisms contained in a biological sample.
  • probes which can be either total genomic deoxyribonucleic acid (DNA), indigenous plasmids, cloned DNA fragments, or synthetic oligonucleotides, target the DNA of the organism to be detected.
  • DNA total genomic deoxyribonucleic acid
  • indigenous plasmids plasmids
  • cloned DNA fragments cloned DNA fragments
  • synthetic oligonucleotides target the DNA of the organism to be detected.
  • ribosomal ribonucleic acid rRNA
  • rRNA derived probes known so far are mainly used to detect large groups of organisms such as Legionella (Wilkinson et al., 1986 ; Edelstein, 1986) or the Pseudomonas fluorescens group (Festl et al., 1986), or to differentiate relatively distantly related species such as Mycoplasma (Goebel et al., 1987) and Chlamydia species (Palmer et al., 1986) from one another.
  • rRNA derived probes could be devised which could not only differentiate between highly related bacterial species but also between taxa related at the subspecies level using a simple direct hybridization format.
  • Neisseria gonorrhoeae strains could be discriminated from other Neisseria strains, including N. meningitidis strains, by means of a dot-spot hybridization assay by some of the probes described herein.
  • an object of the invention is to provide rRNA-related probes for detecting one or more Neisseria strains.
  • Another object of the invention is to provide rRNA-related probes for differentiating Neisseria gonorrhoeae from other bacterial species and in particular from other Neisseria species and from Neisseria meningitidis .
  • a further object of the invention is to provide probes for detecting one or more Neisseria strains by a simple hybridization test, such as a dot-spot hybridization test, without resorting to any complementary analysis, such as the Southern-blot analysis.
  • Still another object of the invention is to provide a probe and a simple method for the in vitro diagnosis of one or more Neisseria strains.
  • rRNA-related refers to the fact that the probes concerned hybridize with sequences normally present in ribosomal RNAs, no matter whether said probes are themselves formed of DNA or RNA fragments, or whether they consist of cloned fragments (in the case of DNA) or of synthetic oligonucleotides.
  • Neisseria as used herein not only refers to bacteria named Neisseria but also to named or unnamed taxa, such as Kingella , Eikenella , Simonsiella , Alysiella and the CDC groups EF-4 and M-5, which are highly interrelated with bacteria belonging to the genus Neisseria . These taxa are found within a Tm(e) range of approximately 6°C versus ribosomal RNA of flavescens ATCC 13120. Tm(e) is defined in Rossau, R., A. Van Landschoot, W. Mannheim, and J. De Ley. 1986. Inter- and intrageneric similarities of ribosomal ribonucleic acid cistrons of the Neisseriaceae . Int. J. Syst. Bacteriol. 36 :323-332.
  • misnamed bacteria which are not found within the delta Tm(e) range indicated, such as Neisseria caviae , Neisseria cuniculi , Neisseria ovis , Neisseria catarrhalis ( Branhamella ( Moraxella ) catarrhalis ), Kingella indologenes and Alysiella sp., do not belong to the Neisseria group.
  • a hybridization probe of the invention for de­tecting one or more Neisseria strains contains : - either a sequence belonging to a nucleic acid selected from the following groups of nucleic acids and which includes itself of from 10 to the maximum number of nucleotides of the selected nucleic acid in which the letters mean the following nucleotides : A : adenylic residue, C : cytidylic residue, G : guanidylic residue, T : thymidylic residue, U : uracylic residue, - or a variant sequence which differs from any of the preceding sequences (4) to (18) . either by addition to or removal from any of their respective extremities of one or several nucleotides, . or changing within any of said sequences of one or more nucleotides, . or both, yet provided that in any of the above circumstances said probe still hybridizes with the same RNA or DNA target as the corresponding unmodified sequence.
  • target is meant a sequence complementary to any of the sequences of groups 4 to 18 as herein before defined.
  • the probe of the invention would comprise nucleic acid elongations on either side or both of said above defined sequences -- e.g. nucleic acid fragments of a cloning vector or linker fragments resulting from the cleavage of said probe out of said cloning vector -- it is understood that such elongations should be selected such as to avoid the possibility that they could themselves hybridize with any other corresponding complementary nucleic acid sequence outside of the above target in a DNA of any microorganism likely to be tested by the process of this invention as later defined. Such hybridization would be of a parasitical nature and reduce the specificity of the probe.
  • Preferred probes consist of nucleic acid fragments formed of any of the sequences under (4) to (18), said fragments containing from 10 to the maximum number of nucleotides of the relevant nucleic acid sequence.
  • probe of group "x"" - with “x" from 1 to 10 - it should be understood that such probe has a sequence included in one of the nucleic acids belonging to that group as defined above or further defined hereinafter.
  • nucleotide refers indistinctly to ribonucleotides and deoxyribonucleotides and modified nucleotides such as inosine unless otherwise specified.
  • the expression “nucleotides” also encompasses those which further comprise modification groups, e.g. chemical modification groups which do not affect their hybridization capabilities. Such modification groups aim, for instance, at facilitating their coupling, either directly or indirectly, with suitable markers or labels for the subsequent detection of the probes so marked or labeled, particularly in their hybridization products with the relevant rRNA or DNA strand, e.g. that or those initially contained in a biological sample together with other DNA(s) and/or RNA(s).
  • modification groups aim, for instance, at facilitating their coupling, either directly or indirectly, with suitable markers or labels for the subsequent detection of the probes so marked or labeled, particularly in their hybridization products with the relevant rRNA or DNA strand, e.g. that or those initially contained in a biological sample together with other DNA(s) and
  • modification groups are recognizable by antibodies which, in turn, can be recognized specifically by other antibodies carrying a suitable enzymatic or fluorescent or chemiluminescent label. Possible labeling procedures will further be examplified later herein.
  • the invention also relates to probes having any of the sequences defined above and in which some nucleotides are different, provided that the different nucleotide(s) do(es) not alter the specificity of the probes defined above.
  • Some probes may consist of one of the nucleic acids belonging to any of the groups 4 to 10 which are set forth above or of part thereof, said probes however including nucleotidic elongation on either sides thereof to the extent that such elongations do not alter the specificity of said probes with the genetic material of Neisseria as discussed hereafter.
  • probes of group 4, 5, 9, 11, 13 and 18 are capable of hybridizing more selectively with corresponding regions of the RNAs or DNAs of Neisseria gonorrhoeae , and in some instances under controlled hybridization conditions - not with other Neisseria .
  • each of said groups comprising more specific probes (still normally containing at least ten nucleotides) whose probes contain : - either a sequence belonging to a nucleic acid selected from the following groups of nucleic acids and which includes itself of from 10 to the maximum number of nucleotides of the selected nucleic acid - or a variant sequence which differs from any of the preceding sequences (1) to (3) . either by addition to or removal from any of their respective extremities of one or several nucleotides, . or changing within any of said sequences of one or more nucleotides, . or both, yet provided that in any of the above circumstances said probe still hybridizes with the same RNA or DNA target as the corresponding unmodified sequence.
  • the invention thus provides for probes which are either replicas (those designated by numbers followed by "ter” or “quater”) in terms of nucleotide sequence of sequences contained in the rRNAs of most Neisseria , with occasionnally a few insignificant differences in nucleotide sequences or formed of sequences, those designated by bare numbers or by numbers followed by "bis", complementary to sequences included in the natural rRNAs of Neisseria .
  • the target sequences in the rRNAs concerned consist in any of the following successive sequences present in most, if not all, Neisseria , subject to possible insignificant natural differences from one Neisseria to another, whereby such natural differences are not likely to affect the hybridization specificity of the probes of this invention with such targets :
  • the differences in hybridization capability of the nucleotide sequences of the different probes (or of (8quater), (9quater), (10quater) the related rRNA sequences) from one probe to another are of a sufficiently reduced magnitude as to ensure the selectivity of the sequences of groups (4)-(18) as regards the detection and identification of Neisseria (such as N. lactamica, N. mucosa, N. subflava, N. flavescens, N. elongata, etc%) in a biological sample suspected to contain same, yet to distinguish them from other taxa.
  • Neisseria such as N. lactamica, N. mucosa, N. subflava, N. flavescens, N. elongata, etc.
  • gonorrhoeae is still retained with probes whose sequences overlap regions of corresponding nucleic acids of groups 1 and either 2 or 3 (or are specifically contained in sequences belonging to the nucleic acids of group 2 or 3 only), (or are specifically contained in sequences contained in the nucleic acids of group 3 only), yet subject to adjusting the hybridization and washing conditions more stringently.
  • the preferred probes are those which are complementary to the natural rRNAs concerned for they hybridize both with said RNAs and the corresponding DNA.
  • Other groups of probes of the invention are constituted by those which are specific for Neisseria strains yet considered globally (as specified above) consist of groups 6, 7, 8, 10, 12, 14, 16 and 17 as above defined, if need be under appropriate adjustment of the hybridizing and washing conditions of the hybrid possibly formed.
  • the probes according to the invention can be formed by cloning of recombinant plasmids containing inserts including the corresponding nucleotide sequences, if need be cleaving the latter out from the cloned plasmids upon using the adequate nucleases and recovering them, e.g. by fractionation according to molecular weights.
  • the probes according to the invention can also be synthetized chemically, for instance by the conventional phospho-triester method.
  • temperatures are valid only under the conditions mentioned above.
  • Other hybridization or wash media can be used as well.
  • the temperatures at which the probes can be used to obtain the required specificity should be changed according to known relationships, such as those described in the following reference : B.D. Hames and S.J. Higgins, (eds.). Nucleic acid hybridization. A practical approach, IRL Press, Oxford, U.K., 1985.
  • Preferred probes of the invention for detecting Neisseria gonorrhoeae strains are those of groups (1) to (4), provided that the probe does not consist of the following sequence: TCA TCG GCC GCC GAT ATT GGC
  • the invention also relates to probes of the above mentioned sequences which can discriminate between organisms with DNA:DNA hybridization homology values between about 55% to about 75%.
  • rRNA derived hybridization probes which allow discrimination between highly related taxa (more than 55 % DNA homology) other than those found within the Neisseria group (e.g. in Bordetella ), can be constructed also.
  • these highly specific probes can be obtained from the sequences found in the same regions of the rRNA molecules than those in which specific sequences for Neisseria gonorrhoeae were found (e.g. regions I, II and III in Fig. 1, in the case of 16S rRNA). These regions can be easily located after proper alignment of the total or partial rRNA sequence of the organism concerned with the rRNA sequence of E. coli . These regions will correspond to the regions found between nucleotides :
  • the invention also relates to a process for detecting Neisseria strains in a biological sample, wherein said process comprises contacting said biological sample in which the nucleic acids (DNAs and RNAs) have been made accessible to hybridization, if need be under suitable denaturation conditions, with a probe of the invention under conditions enabling hybridization between the probe and complementary nucleic acids of the Neisseria strains, which may be present in the sample, and detecting the hybrids possibly formed.
  • the process relates to the detection of Neisseria strains being directly in the sample of after the strain has been cultured.
  • the detection of a hybrid can be interpreted as meaning that a Neisseria infection was present in the biological sample, when any of the probes of groups 1 to 18 is being used, and even more specifically that a Neisseria gonorrhoeae infection was present when the probe used had a sequence belonging to a nucleic acid of groups 4, 5, 9, 11, 13 or 18, possibly under suitable hybridizing conditions, and even more so when the probe had a sequence belonging to a sequence of group 3, group 2 or even more preferably group 1.
  • the probes used are the ones hybridizing both with DNA globally and RNA of the Neisseria strains which may be present in the biological sample.
  • hybridization conditions can be monitored relying upon several parameters, e.g. hybridization temperature, the nature and concentration of the components of the media, and the temperature under which the hybrids formed are washed.
  • the hybridization temperature is limited in upper value, according to the probe (its nucleic acid composition, kind and length) and the maximum hybridization temperature of the probes described herein is about 55°C to 75°C. At higher temperatures duplexing competes with the dissociation (or denaturation) of the hybrid formed between the probe and the target.
  • the hybridization temperature is preferably comprised from about 45°C to about 70°C, particularly from about 45°C to about 65°C.
  • the washing temperature is comprised in the range from about 50°C to about 75°C.
  • the process for detecting Neisseria strains generally, according to the invention can be carried out by suitably adjusting the hybridization temperature to a value at which hybridization is specific, and in such a case washing under more stringent conditions is not necessary.
  • the hybridization temperature needs not necessarily be adjusted to the value at which hybridi­zation is specific and in particular can be lower than the temperature at which hybridization is specific, provided washing is carried out at a temperature corresponding to the value at which hybridization is specific.
  • the hybridization temperature is suitably adjusted to range of about 65°C and/or the wash temperature to range from about 65°C to about 70°C, the media being those above defined.
  • the hybridization temperature is suitably adjusted to range of about 55°C and/or the wash temperature to range of about 55°C.
  • the probe used is anyone of group 1 above defined.
  • the hybridization temperature is suitably adjusted to range of about 55°C, preferably of about 53°C, and/or the wash temperature to range of about 55°C, pre­ferably of about 53°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 2 above defined.
  • the hybridization temperature is suitably adjusted to range of about 60°C and/or the wash temperature to range of about 60°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 3 above defined.
  • the hybridization temperature is suitably adjusted to range of about 60°C and/or the wash tempera­ture to range of about 60°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 4 above defined.
  • the hybridization temperature is suitably adjusted to range of about 65°C and/or the wash temperature to range of about 65°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 5 above defined.
  • the hybridization temperature is suitably adjusted to range of about 55°C and/or the wash tempe­rature to range of about 55°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 8 above defined.
  • the hybridization temperature is suitably adjusted to range of about 55°C and/or the wash tempe­rature to range of about 55°C to about 60°C, the hybri­dization medium being the one above defined.
  • the probe used is anyone of group 9 above defined.
  • the hybridization temperature is suitably adjusted to range of about 60°C and/or the wash tempera­ture to range of about 60°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 10 above defined.
  • the hybridization temperature is suitably adjusted to range of about 55°C and/or the wash tempera­ture to range of about 55°C to about 60°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 11 above defined.
  • the hybridization temperature is suitably adjusted to range of about 55°C and/or the wash tempera­ture to range of about 55°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 12 above defined.
  • the hybridization temperature is suitably adjusted to range of about 55°C to about 60°C and/or the wash temperature to range of about 55°C to about 60°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 13 above defined.
  • the hybridization temperature is suitably adjusted to range of about 45°C and/or the wash tempera­ture to range of about 45°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 14 above defined.
  • the hybridization temperature is suitably adjusted to range of about 40°C to about 45°C and/or the wash temperature to range of about 40°C to about 45°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 15 above defined.
  • the hybridization temperature is suitably adjusted to range of about 50°C to about 55°C and/or the wash temperature to range of about 50°C to about 55°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 16 above defined.
  • the hybridization temperature is suitably adjusted to range of about 50°C to about 60°C and/or the wash temperature to range of about 50°C to about 60°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 17 above defined.
  • the hybridization temperature is suitably adjusted to range of about 50°C to about 55°C and/or the wash temperature to range of about 50°C to about 55°C, the hybridization medium being the one above defined.
  • the probe used is anyone of group 18 above defined.
  • the hybridization temperature is suitably adjusted to range of about 45°C and/or the wash tempera­ture to range of about 45°C, the hybridization medium being the one above defined.
  • the invention further relates also to a process for detecting Neisseria gonorrhoeae strains from other Neisseria strains in a biological sample, and advanta­geously for differentiating Neisseria gonorrhoeae strains from highly related taxa such as N.
  • said process comprises contacting said biological sample, in which the nucleic acids (DNAs and RNAs) have been made accessible to hybridization, if need be, under suitable denaturation conditions, with a probe of the invention specific for Neisseria gonorrhoeae strains and selected from groups 1 to 5, 9, 11, 13 and 18, whenever required, under hybridization and washing conditions adjusted such as to ensure specific hybridization with complementary nucleic acids of the Neisseria gonorrhoeae strains, which may be present in the sample, yet not wth complementary DNA or RNA of other Neisseria species, and detecting the hybrids possibly formed.
  • a probe of the invention specific for Neisseria gonorrhoeae strains and selected from groups 1 to 5, 9, 11, 13 and 18, whenever required
  • Neisseria strains from which the N. gonorrhoeae strains can be specifically differentiated are for instance N. lactamica , N. mucosa , N. subflava, N. flavescens, and N. elongata.
  • the hybridization temperature is preferably comprised from about 50°C to about 75°C.
  • the wash temperature is comprised from about 50°C to about 70°C.
  • the probe used belongs to group 2 above de­fined, the hybridization temperature is suitably adjusted to range about 60°C, and/or the wash temperature to range from about 65°C to about 70°C, preferably about 65°C, the medium being the one above defined.
  • the probe used belongs to group 3 above defined, the hybridization temperature is suitably adjusted to range of about 60°C, and/or the wash temperature to range from about 65°C to about 70°C, preferably about 65°C, the medium being the one above defined.
  • the probe used belongs to group 4 above defined, the hybridization temperature is suitably adjusted to range of about 65°C, and/or the wash temperature for range from about 70°C to about 75°C, preferably about 70°C.
  • the probe used belongs to group 5 above defined, the hybridization temperature is suitably adjusted to range of about 60°C, and/or the wash tempera­ture to range of about 65°C.
  • the probe used belongs to group 9 above defined, the hybridization temperature is suitably adjusted to range of about 60°C to about 65°C, and the wash temperature to range of about 65°C.
  • the probe used belongs to group 13 above de­fined, the hybridization temperature is suitably adjusted to range about 50°C to about 55°C, and/or the wash temperature to range from about 50°C to about 55°C, the medium being the one above defined.
  • the probe used belongs to group 18 above de­fined, the hybridization temperature is suitably adjusted to range about 60°C, and/or the wash temperature to range about 60°C, the medium being the one above defined.
  • the probe used belongs to group 1 above defined, the hybridization temperature is suitably adjusted to range of about 55°C, preferably of about 53°C, and/or the wash temperature to range from about 55°C to about 65°C, preferably from about 53°C to about 65°C, more preferably of about 53°C.
  • the probe used belongs to anyone of groups (1) to (4), provided that the probe does not consist of the following sequence: TCA TCG GCC GCC GAT ATT GGC
  • the invention also relates to a kit for the detection in vitro of a large number, preferably all Neisseria strains in a biological sample containing : - at least one probe selected among any of those which have been defined above ; - the buffer or components necessary for producing the buffer enabling an hybridization reaction between these probes and the DNAs and/or RNAs of a strain of Neisseria to be carried out, - when appropriate means for detecting the hybrids resulting from the preceding hybridization.
  • the invention further relates to a kit for detecting specifically N. gonorrhoeae strains containing : - at least one probe selected among any of those that are specific for N. gonorrhoeae as above defined, e.g. a probe of groups (2), (3), (4), (5), (9), (11), (13) or (18), preferably a probe of group (1) ; - the buffer or components necessary for producing the buffer enabling an hybridization reaction between these probes and only the DNAs and/or RNAs of a strain of Neisseria gonorrhoeae to be carried out.
  • the probe belongs to groups (1) to (4), provi­ded that the probe does not consist of the following sequence: TCA TCG GCC GCC GAT ATT GGC
  • the invention relates to a kit for detecting a large number, preferably all Neisseria strains and specifically Neisseria gonorrhoeae strains containing : - at least one probe selected among any of those that have been above defined, e.g.
  • the pro­be used for detecting N. gonorrhoeae strains belongs to groups (1) to (4) provided that the probe does not consist of the following sequence: TCA TCG GCC GCC GAT ATT GGC
  • the probes of the invention are advantageously labeled. Any conventional label can be used.
  • the probes can be labeled by means of radioactive tracers such as 32P, 35S, 125I, 3H and 14C.
  • the radioactive labeling can be carried out according to any conventional method such as terminal labeling at the 3′ or 5′ position with the use of a radio-labeled nucleotide, a polynucleotide kinase (with or without dephosphorylation by a phosphatase) or a ligase (according to the extremity to be labeled).
  • One of the probes of the invention can be the matrix for the synthesis of a chain consisting of several radioactive nucleotides or of several radioactive and non radioactive nucleotides.
  • the probes of the invention can also be prepared by a chemical synthesis using one or several radioactive nucleotides.
  • Another method for ra­dioactive labeling is a chemical iodination of the probes of the invention which leads to the binding of several 125I atoms on the probes.
  • one of the probes of the invention is made radioactive to be used for hybridization with a non radioactive RNA or DNA
  • the method of detecting hybridi­zation will depend on the radioactive tracer used. Gene­rally, autoradiography, liquid scintillation, gamma counting or any other conventional method enabling one to detect an ionizing ray issued by the radioactive tra­cer can be used.
  • Non radioactive labeling can also be used by associating the probes of the invention with residues having : immunological properties (e.g. antigen or hapten), a specific affinity for some reagents (e.g. ligand), properties providing a detectable enzymatic reaction (e.g. enzyme, co-enzyme, enzyme substrate or substrate taking part in an enzymatic reaction), or physical properties such as fluorescence or emission or absorbtion of light at any wave length.
  • immunological properties e.g. antigen or hapten
  • a specific affinity for some reagents e.g. ligand
  • properties providing a detectable enzymatic reaction e.g. enzyme, co-enzyme, enzyme substrate or substrate taking part in an enzymatic reaction
  • physical properties such as fluorescence or emission or absorbtion of light at any wave length.
  • Antibodies which specifically detect the hybrids formed by the probe and the target can also be used.
  • a non-radioactive label can be provided when chemically synthesising a probe of the invention, the adenosine, guanosine, cytidine, thymidine and uracyl residues, thereof being liable to be coupled to other chemical residues enabling the detection of the probe or the hybrids formed between the probe and a complementary DNA or RNA fragment.
  • the nucleotide sequence of the probe when modified by coupling one or more nucleo­tides to other chemical residues would be the same as the nucleotidic sequence of one of the probes of the invention.
  • the invention also relates to processes for detecting by hybridization RNA and/or DNA with the pro­bes of the invention, which have been labeled and can be detected as described above.
  • conven­tional methods of hybridization can be used.
  • the RNA and/or DNA of these cells is made accessible by partial or total lysis of the cells, using chemical or physical processes, and contacted with one or several probes of the invention which can be detected.
  • This contact can be carried out on an appropriate support such as a nitrocellulose, cellulose, or nylon filter in a liquid medium or in solution.
  • This contact can take place under sub-optimal, optimal conditions or under restrictive conditions (i.e. conditions enabling hybrid formation only if the sequences are perfectly homologous on a length of molecule).
  • Such conditions include tem­perature, concentration of reactants, the presence of substances lowering the optimal temperature of pairing of nucleic acids (e.g. formamide, dimethylsulfoxide and urea) and the presence of substances apparently lowering the reaction volume and/or accelerating hybrid formation (e.g. dextran sulfate, polyethyleneglycol or phenol).
  • probe of the invention which has not hybridized can be carried out by washing with a buffer solution of appropriate ionic strength and at an appropriate temperature, with or without treatment with S1 nuclease or any other enzyme digesting single strand DNA or RNA but not digesting DNA-RNA hybrids or double strand DNA.
  • the hybrids of the probes of the invention paired to the cellular DNA or RNA fragments can be separated from the rest of the liquid medium in different ways, e.g. by chromatography over hydroxyapatite.
  • the hybridized probes are detected by means of the label on the probe.
  • one of the probes of the invention is contacted with the DNA fragments under the conditions enabling hybridization and after the time necessary to get to the end of the hybridization, the non-hybridized fragments are separated from the hybridized fragments and the la­bel is detected as it has been described above for the detection of the cells.
  • the different probes of the invention can also be contained in recombinant DNA enabling their cloning, if the presence of a heterolo­gous DNA is not a nuisance for the specificity of the probes in the encompassed uses.
  • the examples hereafter relate to the preparation of the probes of the invention respectively corresponding to the sequences (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17) and (18) above described and hereafter mentioned respectively as probes n° 1, n°2, n° 3, n° 4, n° 5, n° 6, n° 7, n° 8, n° 9, n° 10, n° 11, n° 12, n° 13, n° 14, n° 15, n° 16, n° 17 and n° 18.
  • Neisseria gonorrhoeae NCTC 8375 T Neisseria meningitidis NCTC 10025 T , Neisseria lactamica NCTC 10617 T , Neisseria mucosa CIP 59.51 T , Neisseria subflava ATCC 10555, Neisseria flavescens ATCC 13120 T , Neisseria elongata ssp. elongata NCTC 10660 T , and Moraxella ( Branhamella ) catarrhalis NCTC4103. Eight randomly chosen N. gonorrhoeae strains and nine N.
  • meningitidis strains (from different serotypes) were cultured overnight on blood agar plates at the Institute of Tropical Medicine, Antwerp, Belgium. The identity of the strains was checked by conventional methods. Purified genomic DNA from the re­maining strains was provided by J. De Ley (Lab. Microbiology, State University Gent, Belgium).
  • High-molecular weight genomic DNA was prepared essentially by the method described by Marmur (1961). Plasmid DNA was isolated by the method described by Kahn at al. (1979) and purified by CsCl-gradient centrifugation.
  • the DNA solution was heated for 10 min. at 95°C, put on ice, and adjusted to 6XSSC (SSC : 0.15M NaCl, 0.015M sodium citrate, pH 7.0). The appropriate amount of solution was applied to a BA85 membrane (Schleicher & Schuell, W.-Germany) in a dot-spot manifold. After air dry­ing, the membrane was baked at 80°C for 2 h.
  • the plasmids pNGD1 and pNGK3 contain the probes n° 3 and n° 6 as an insert respectively. They were constructed from pNG4 and pNG3 respectively, which are pTZ18R (Pharmacia, Sweden) derived recombinant plasmids which contain part of the 16S rRNA gene of Neisseria gonorrhoeae NCTC 8375 T .
  • pNGD1 a 71 basepair StuI-KpnI fragment was subcloned and 25 basepairs beginning from the StuI site were subsequently removed by Exonuclease III (Stratagene, U.S.A.) and mung bean nuclease (Stratagene, U.S.A.) treatment.
  • Exonuclease III Stratagene, U.S.A.
  • mung bean nuclease Stratagene, U.S.A.
  • 63 basepairs were likewise removed from the 3′ end of the insert of pNG3.
  • the resulting plasmid was cleaved with SphI and BstXI, followed by blunting of the sticky-ends and intramolecular ligation.
  • the restriction enzymes were purchased from Boehringer Mannheim (W.-Germany) or Bio Labs (U.S.A.) and used as recommended by the suppliers.
  • the inserts of pNGD1 and pNGK3 were sequenced by the dideoxy chain-termination method on supercoiled plasmid DNA as described in the GemSeq K/RTTM Sequencing System technical manual (Promega, U.S.A.).
  • the oligonucleotides were synthetized by the phosphite-triester method on a Gene Assembler 18-5800-01 (Pharmacia, Sweden) or a Cyclone 8400 (New Brunswick, U.S.A.).
  • the deprotected oligonucleotides were purified on a 15% polyacrylamide gel in 7M ureum. After overnight elu­tion, they were desalted on a Sephadex G-25 (Pharmacia, Sweden) column.
  • the synthetic oligonucleotides used as probes were labeled using T4-polynucleotide kinase (Pharmacia, Sweden) and gamma-32P-dATP (Amersham, U.K.) (Maniatis et al., 1982).
  • the inserts of pNGD1 and pNGK3 were cut out using restriction enzymes and purified by agarose gel electrophoresis.
  • the purified inserts were labeled by filling in the sticky-ends with alpha-32P-dATP (Amersham, U.K.) using Klenow enzyme (Boehringer Mannheim, W.-Germany) (Maniatis et al., 1982). Unincorporated label was removed using a Bio-Gel P-6DG (Bio-Rad Laboratories, U.S.A.) spin-­column.
  • Hybridization was usually performed in plastic bags in 3xSSC, 25 mM phosphate buffer pH 7.1 (FB), 20% deionized formamide (FA), 0.02% ficoll, 0.02% bovine serum albumin, 0.02% polyvinylpyrrolidone, and 0.1mg/ml sheared, denatured salmon sperm DNA at the same temperature as the hybridization for 30 min. to 4 h.
  • Hybridizations were performed during 1 h to overnight in the same solution to which approximately 0.5 to 1 x 106 cpm/ml 32P-probe was added.
  • the hybridization temperature (HT) varied from experiment to experiment.
  • the membranes were washed for 15 to 30 min. in 3xSSC, 25mM FB and 20% FA at the wash temperature (WT) indicated in the figures. Afterwards the membranes were rinsed in 1.5xSSC at room temperature for approximately 10 min., dried and autoradiographed.
  • one of the rRNA cistrons of the type strain of N. gonorrohoeae was cloned and sequenced. Evolutionarily less-conserved regions within the cistron were identified by alignment with known sequences. Some of the regions were subcloned (probes n° 3 and 6) or chemically synthesized (probes n° 1, 2, 4, 5, 7, 8, 9, 10, 11 12, 13, 14, 15, 16, 17 and 18) and used as hybridization probes. Fig.
  • Probe n° 9 was derived from region I
  • probes n° 1 to 4 were derived from region II
  • probes n° 5 and 6 from regions III and IV respectively.
  • n° 1, n° 2, n° 3, n° 4, n° 5, n° 6 and n° 9 are aligned with the corresponding sequences of Pseudomonas testosteroni ATCC 11996 (Yang et al., 1985), the closest phylogenetic neighbour of Neisseria from which the 16S rRNA sequence is published and with the corresponding sequences of Escherichia coli (Brosius et al., 1978).
  • Fig. 3 the complementary sequences of probes n° 7, n° 8, n° 10 and n° 11 derived from the 23S rRNA gene are aligned with the corresponding Escherichia coli sequences (Brosius et al., 1980).
  • probes n° 7 and n° 8 were derived from the same region in the 23S rRNA.
  • the sequence of probe n° 8 is identical to the sequence of probe n° 7, except that in probe n° 8 an adenosine residue was inserted (see Fig. 3). From all other regions one probe only was used in the experiments.
  • Figure 11 represents the allocations of the regions from which probes of the invention were constructed on the presumptive 16S rRNA recombinant structure of Neisseria gonorrhoeae .
  • Figure 12 represents the allocation of the regions from which probes of the invention were constructed on the 23S rRNA secondary structure of Escherichia coli (Noller, Ann. Rev. Biochem. 53 : 119-162, 1984).
  • the criterion for specificity was the ability to differentiate between Neisseria gonorrhoeae and N. meningitidis strains.
  • Several independent studies (Kingsbury, 1967 ; Elwell and Falkow, 1977 ; Hoke and Vedros, 1982 ; Riou at al., 1983 ; Guibourdenche et al., 1986) have shown that, despite their distinct pathogenic character both species are genotypically extremely highly related.
  • the DNA:DNA hybridization homology values reported between representatives of both species range between 64 and 93%.
  • the autoradiographs in Fig. 5 show that the probes n° 1, n° 5 and n° 9 duplex with the DNA from all N. gonorrhoeae strains tested.
  • Probes N° 5 and n° 9 were specific for N. gonorrhoeae strains at high stringencies only (for instance hybridization temperature of 55°C, wash temperature of 65°C, in the case of probe n° 5) whereas probe n° 1 remained specific at low stringency conditions (hybridization temperature of 50°C, wash temperature of 50°C or 55°C).
  • hybridization temperature for instance hybridization temperature of 55°C, wash temperature of 65°C, in the case of probe n° 5
  • probe n° 1 remained specific at low stringency conditions (hybridization temperature of 50°C, wash temperature of 50°C or 55°C).
  • a taxon-specific rRNA-derived DNA-probe does not detect nucleic acid from closely related organisms, the probability that it will detect nucleic acid from more remotely organisms can considered to be very small.
  • Fig. 6 corresponding to an experiment in which probes n° 3, n° 5, n° 6 and n° 7 were hybridized with genomic DNA of seven Neisseria species and some other Gram-negative bacteria. More precisely, Fig. 6 represents hybridization results of selected rRNA-derived DNA-probes with one ⁇ g of denatured DNA of Neisseria gonorrhoeae NCTC 8375 T (row A,1), N. meningitidis NCTC 10025 T (row B,1), N.
  • lactamica NCTC 10617 T (row C,1), N. mucosa CIP 59.51 T (row D,1), N. subflava ATCC 10555 (row E,1), N. flavescens ATCC 13120 T (row F,1), N. elongata ssp.
  • probe n° 6 did hybridize with DNA from the type strain of Simonsiella crassa at 60°C in 3SSC and 20% FA.
  • this probe duplexes with N. gonorrhoeae and N . meningitidis DNA, and at 60°C with DNA from the three Neisseria species tested. However, even non-neisserial DNA could be detected when the wash temperature was 50°C.
  • Table I summarizes the temperature range in which the probes of the invention are specific for N. gonorrhoeae . For each probe this temperature range is between Ts and Td. Ts is the lowest temperature at which the probe is still specific for N. gonorrhoeae and Td is the temperature at which the probe-target duplex is completely dissociated. These values were obtained under the following conditions : 3 SSC, 25 mM FB pH 7.1 and 20% FA. If these conditions the nature of the probe or the target are changed, the temperatures will change accordingly. The temperatures were experimentally determined using intervals of 5°C, hence the delta 5°C range of Ts and Td.
  • probe n° 1 may also be specific at a temperature lower than 45-50°C and that probes n° 6, n° 7, n° 8 and n° 10 are not specific for Neisseria gonorrhoeae .
  • TABLE I Probe Ts(°C) Td(°C) 1 45-50 65-70 2 55-60 70-75 3 60-65 70-75 4 65-70 75-80 5 60-65 65-70 6 - 70-75 7 - 55-60 8 - 60-65 9 60-65 65-70 10 - 65-70 11 60-65 65-70
  • Probe n° 1 was extensively tested using 202 N. gonorrhoeae strains and 84 N. meningitidis strains.
  • each number represents either a Neisseria gonorrhoeae or a N. meningitidis strain.
  • the N. meningitidis strains are boxed.
  • probe n° 1 also hybridized to DNA of Neisseria species strain ATCC 43831 (see Fig. 16).
  • Figure 16 the hybridization results with probe n° 1 and DNA of Neisseria species strain ATCC 43831 are represented: the hybridization and wash temperature was 52.5°C (in 3SSC, 25 mM PB ⁇ pH 7.1 and 20% FA).
  • This ATCC 43831 strain is an unclassified strain with intermediate characteristics between N. gonorrhoeae and N. menigitid i s .
  • probe n° 1 did not cross-hybridize with DNA of a variety of other bacteria.
  • probe n°1 proved to be 100% specific and 100% reliable for N. gonorrhoeae as compared to conventional identification techniques.
  • the probe also proved to be more reliable than the cryptic plasmid probe initially described by Totten et al., J. Infect. Dis., 148 :462-471, 1983 (results not shown).
  • the hybridization temperature was 55°C (in 3SSC, 25 mM PB, pH 7.1 and 20% FA).
  • the wash temperatures are indicated (the same medium was used).
  • the location of the strains is given in Table II.
  • Probe n°10 hybridizes to DNA of almost all Neisseria strain. At 60°C weak crossreactions are observed also with DNA from Simonsiella and Alysiella strains, which are close relatives of the neisseriae (Rossau et al., IJSB, 1989 in press).
  • probes n°12 to n° 18 were tested as described hereabove (same method, same media).
  • the membranes Following hybridization at the temperature (HT) and with the probe indicated, the membranes, on which 1 ⁇ g of denatured DNA of Neisseria gonorrhoeae NCTC 8375T (NG), Neisseria meningitidis NCTC 10025T (NM), Escherichia coli B (EC) and Branhamella catarrhalis ITG 4197 (BC) was spotted, were washed for 15 min. at the indicated wash temperature, dried and autoradiographed for 24 h. with an intensifying screen at 70°C.
  • NG Neisseria gonorrhoeae NCTC 8375T
  • NM Neisseria meningitidis NCTC 10025T
  • EC Escherichia coli B
  • BC Branhamella catarrhalis ITG 4197
  • probes n° 12, 14 and 17 are not specific for Neisseria gonorrhoeae . They can be used to detect one or more Neisseria strains at the following hybridization temperature (HT) and wash temperature (WT): probe n° 12: HT and WT between about 55°C and about 60°C probe n° 14: HT and WT between about 40°C and about 45°C probe n° 17: HT and WT between about 50°C and about 55°C
  • HT hybridization temperature
  • WT wash temperature
  • probes n° 15 and 16 do not hybridize with DNA of the type strain of N. meningitidis under stringent conditions (see Figure 13), further experiments showed that they are not sufficiently specific for N. gonorrhoeae as they crosshybridize to some other Neisseria strains, mainly N. meningitidis strains. Both probes can thus be used only to detect one or more Neisseria strains at the following HT and WT: probe n° 15: HT and WT between about 50°C and about 55°C probe n° 16: HT and WT between about 50°C and about 60°C.
  • probes n° 13 and 18 hybridized to all N. gonorrhoeae strains tested and not with any of the N. meningitidis strains tested at the following HT and WT: probe n° 13: HT and WT from about 50 to about 55°C probe n° 18: about 60°C
  • Probe n° 18 was hybridized with 1 ⁇ g denatured dot-spotted DNA from 9 N. gonorrhoeae strains (row A, B and C, 1 to 3), 10 N. meningitidis strains (row D, E and F, 1 to 3 and row G, 1) and two reference strains not related to Neisseria (row G, 2 and 3).
  • the hybridization and wash temperature was 60°C.
  • Table III summarizes the temperature range in which the probes n° 12 and n° 18 of the invention are specific for N. gonorrhoeae .
  • Ts and Td have the meaning above explained under the conditions hereabove detailed (cf. Table I).
  • TABLE III Probe Ts(°C) Td(°C) 12 - 60-65 13 50-55 55-60 14 - 45-50 15 - 55-60 16 - 60-65 17 55-60 18 55-60 60-65
  • the probes of the invention can be used in a sandwich hybridization system which enhances the specificity of a nucleic acid probe based assay.
  • sandwich hybridizations in a nucleic acid probe based assay have been already described (e.g.: Dunn and Hassel, Cell, 12 : 23-36, 1977; Ranki et al., Gene 21 , 77-85, 1983).
  • direct hybridization assays have favourable kinetics
  • sandwich hybridizations are advantageous with respect to a higher signal to noise ratio.
  • sandwich hybridizations can enhance the specificity of a nucleic acid probe based assay. If properly designed, a sandwich hybridization assay indeed maximizes the specificity of a nucleic acid probe based test when using two probes recognizing two different nucleic acid stretches of one and the same organism. The only demands which must be met are that both probes (i) hybridize to nucleic acid of the target organism and (ii) do not hybridize to the same non-target organisms.
  • the sandwich hybridization system can be described as follows:
  • Probe n° I hybridizes to nucleic acid from organisms A and B (not with C).
  • Probe n° II hybridizes to nucleic acid from organisms A and C (not with B).
  • a sandwich hybridization assay with enhanced specificity is represented: - Probe I hybridizes with nucleic acid from organisms A and B and is fixed to the solid support. - Probe II hybridizes with nucleic acid from organisms A and C and is labeled.
  • test will be positive only if the labeled probe (probe II) will become indirectly fixed to the support, i.e. if nucleic acid from organism A is present.
  • probe I and probe II hybridize with the target nucleic acid (A).
  • the labeled probe is fixed.
  • the test is positive.
  • probe I hybridizes with nucleic acid from organism B, but probe II does not.
  • the labeled probe is not fixed. There will be no signal ; the test is negative.
  • nucleic acid from organism C is not fixed. Consequently the labeled probe is not fixed. There will be not signal ; the test is negative.
  • probes of the invention can be combined in a sandwich hybridization assay which is highly specific for Neisseria gonorrhoeae .
  • Advantageous combinations of probes of the invention which maximize the specificity for N. gonorrhoeae are: - probe of group 9 and anyone of the probes of the following groups: 1, 2, 3, 5 and 13. - probe of group 13 and anyone of the probes of the following groups: 1, 2, 3 and 5. - probe of group 18 and anyone of the probes of the following groups: 1, 2, 3, 5, 9 and 13. - probe of group 5 and anyone of the probes of the following groups: 1, 2 and 3.
  • Preferred combinations of probes of the invention which are specific for N. gonorrhoeae are the following ones: - probe of group 9 and of group 5. - probe of group 18 and one of the probes of the following groups: 5 and 9.
  • the probes can be added simultaneously or not, to the biological sample in which the target DNA or RNA is sought.
  • This Table represents preferred approximate hybridization and wash temperatures (in °C) for the different combinations of probes in a sandwich hybridization assay. The combinations indicated by "-" should not be used.
  • an assay in which probes n° 1 and n° 5 are combined should be performed at about 53°C
  • - an assay in which probes n° 18 and n° 9 are combined should be performed at about 60°C.
  • the invention also relates to a kit for sandwich hybridization assay, for the detection in vitro of Neisseria gonorrhoeae strains in a biological sample, said kit containing : - at least two probes specific for N. gonorrhoeae as above selected from the following combinations: - probe of group 9 and anyone of the probes of the following groups: 1, 2, 3, 5 and 13. - probe of group 13 and anyone of the probes of the following groups: 1, 2, 3 and 5. - probe of group 18 and anyone of the probes of the following groups: 1, 2, 3, 5, 9 and 13.
  • Neisseria gonorrhoeae and Neisseria meningitidis strains can be distinguished from each other by some of the probes of the invention has some widespread implications on the use of rRNA-derived probes in general, because both taxa are genotypically related at the subspecies level.
  • the probes according to the invention cannot be used exclusively to detect large groups of organisms, but can be used also to differentiate between organisms at the subspecies level. There is no reason to believe that this should be the case in Neisseria only, and not in other taxa. Provided that the probe sequence and the hybridization conditions are carefully chosen, differentiation at the subspecies level can be accomplished in a simple direct hybridization format, making the tedious Southern-blot analysis obsolete.
  • the specific probes of the invention in particular probes n° 1 to n° 5, n° 9, n° 11, n° 13 and n°18 should find application in the culture confirmation of Neisseria gonorrhoeae and the diagnosis of N. gonorrhoeae in all types of clinical samples, since no interference is to be expected from other microorganisms under the appropriate conditions.
  • the probes of the invention can be used for taxonomic or epidemiological investigations based on restriction fragment length polymorphism analysis (Grimont and Grimont, 1986), or to identify and classify related microorganisms.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
EP89401045A 1988-04-15 1989-04-14 Hybridisationssonden zum Nachweis von Neisseria-Stämme Expired - Lifetime EP0337896B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT89401045T ATE92111T1 (de) 1988-04-15 1989-04-14 Hybridisationssonden zum nachweis von neisseria- staemme.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88400929 1988-04-15
EP88400929 1988-04-15

Publications (2)

Publication Number Publication Date
EP0337896A1 true EP0337896A1 (de) 1989-10-18
EP0337896B1 EP0337896B1 (de) 1993-07-28

Family

ID=8200378

Family Applications (1)

Application Number Title Priority Date Filing Date
EP89401045A Expired - Lifetime EP0337896B1 (de) 1988-04-15 1989-04-14 Hybridisationssonden zum Nachweis von Neisseria-Stämme

Country Status (6)

Country Link
EP (1) EP0337896B1 (de)
JP (1) JPH02203800A (de)
AU (1) AU615286B2 (de)
CA (1) CA1339261C (de)
DE (1) DE68907772T2 (de)
ES (1) ES2058566T3 (de)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393743A2 (de) * 1989-04-17 1990-10-24 Eastman Kodak Company Diagnoseausrüstung, Primerzusammensetzung und ihre Verwendung zur Erwiderung oder zum Nachweis von Nukleinsäuren
WO1990014442A1 (en) * 1989-05-24 1990-11-29 Gene-Trak Systems Nucleic acid probes for the detection of neisseria gonorrhoeae
EP0408077A2 (de) * 1989-07-14 1991-01-16 Roche Diagnostics GmbH Neisseria gonorrhoeae-spezifische Oligonuleotid-Sonden
EP0439968A1 (de) * 1990-02-02 1991-08-07 N.V. Innogenetics S.A. Hybridisierungssonden, zum Nachweis von Stämmen von Haemophylus Ducreyi
EP0452596A1 (de) * 1990-04-18 1991-10-23 N.V. Innogenetics S.A. Hibridizierungssonden aus dem Abstandsbereich zwischen den 16S- und 23S-rRNA-Genen und Nachweis von nichtviralen Mikroorganismen
WO1992005280A1 (en) * 1990-09-21 1992-04-02 Imperial Cancer Research Technology Limited Identification of organisms
US5162199A (en) * 1989-06-22 1992-11-10 Boehringer Mannheim Gmbh Neisseria-specific dna probe
US5217862A (en) * 1989-05-24 1993-06-08 Amoco Corporation Method for the detection of Neisseria gonorrhoeae
GB2262987A (en) * 1990-09-21 1993-07-07 Imp Cancer Res Tech Identification of organisms
US5256536A (en) * 1990-11-09 1993-10-26 Syntex (U.S.A.) Inc. Nucleotide probe for Neisseria gonrrhoeae
EP0574852A2 (de) * 1992-06-17 1993-12-22 Roche Diagnostics GmbH Spezifischer Nachweis von Neisseria Gonorrhoeae
US5389515A (en) * 1992-09-15 1995-02-14 Boehringer Mannheim Corporation Isolated nucleotide sequences for identifying Neisseria gonorrhoeae
EP0630971A3 (de) * 1993-06-23 1995-10-25 Hoffmann La Roche Verfahren, Reagenzien und Testkits zur Detektion von Neisseria Gonorrhoea.
EP0690929A1 (de) * 1994-01-21 1996-01-10 Amoco Corporation NUKLEINSÄUREPROBEN ZUR DETEKTION VON -i(HAEMOPHILUS INFLUENZA)
US5536638A (en) * 1990-04-18 1996-07-16 N.V. Innogenetics S.A. Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of Neisseria gonorrhoeae
EP0747489A2 (de) * 1995-06-07 1996-12-11 Gen-Probe Incorporated Nucleinsäuresonden und Amplifizierungsoligonukleotide für Neisseria Spezies
US5654418A (en) * 1990-10-19 1997-08-05 Becton Dickinson And Company Nucleic acid probes useful for detecting microorganisms associated with vaginal infections
FR2751000A1 (fr) * 1996-07-12 1998-01-16 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
US6100027A (en) * 1995-06-07 2000-08-08 Gen-Probe Incorporated Nucleic acid probes and amplification oligonucleotides for Neisseria species
WO2001023604A2 (en) 1999-09-28 2001-04-05 Infectio Diagnostic (I.D.I.) Inc. Highly conserved genes and their use to generate probes and primers for detection of microorganisms
AU734526B2 (en) * 1995-06-07 2001-06-14 Gen-Probe Incorporated Nucleic acid probes and amplification oligonucleotides for neisseria species
KR100532665B1 (ko) * 2002-11-28 2005-12-02 주식회사 바이오메드랩 나이세리아속 균 탐지용 프로브, 이를 이용한나이세리아속 균의 유전형 분석키트 및 유전형 분석방법
EP2128268A1 (de) 1996-11-04 2009-12-02 Geneohm Sciences Canada Inc. Artenspezifische, geschlechtsspezifische Universal-DNA-Sonden und Amplifikationsprimer zur schnellen Detektion und Identifizierung von herkömmlichen bakteriellen und fungiziden Pathogenen und zugehörige antibiotika-resistente Gene aus klinischen Proben zur Diagnosen in mikrobiologischen Laboratorien
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
US7943346B2 (en) 1994-09-12 2011-05-17 Geneohm Sciences Canada Inc. Probes and primers for detection of bacterial pathogens and antibiotic resistance genes
EP1254254B1 (de) * 1999-09-24 2011-11-09 Biotecon Diagnostics GmbH Nukleinsäuremoleküle zum nachweis von bakterien und phylogenetischen einheiten von bakterien
US8426137B2 (en) 1996-11-04 2013-04-23 Genohm Sciences Canada, Inc. Methods and probes for detecting a vancomycin resistance gene
US9139866B2 (en) 2006-02-17 2015-09-22 Morinaga Milk Industry Co., Ltd. Method for detection of microorganism and kit for detection of microorganism
CN105199948A (zh) * 2015-09-29 2015-12-30 窦晓鸣 大肠杆菌的快速检验试剂盒及检测方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6679836B2 (ja) * 2015-04-08 2020-04-15 東ソー株式会社 淋菌を検出するためのオリゴヌクレオチドプライマーおよび当該プライマーを用いた淋菌の検出方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155359A1 (de) * 1981-09-25 1985-09-25 John A. Webster, Jr. Verfahren zur Identifizierung und Charakterisierung von Organismen
EP0237737A2 (de) * 1986-01-30 1987-09-23 Enzo Biochem, Inc. Eine Zusammensetzung, spezifisch für Neisseria-Gonorrhoeae
EP0245129A1 (de) * 1986-04-04 1987-11-11 Institut Pasteur Oligonukleotid-Sonden und Verfahren zum Nachweis mittels Hybridisierung von Nukleinsäuren in Bakterien und anderen Lebewesen
EP0250662A1 (de) * 1986-06-25 1988-01-07 The Regents Of The University Of California Nachweis von Mykoplasma durch Hybridisierung von DNS
EP0272009A2 (de) * 1986-11-24 1988-06-22 James John Hogan Nukleinsäuresonden zum Nachweis und/oder zur Quantifizierung von nicht-viralen Organismen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155359A1 (de) * 1981-09-25 1985-09-25 John A. Webster, Jr. Verfahren zur Identifizierung und Charakterisierung von Organismen
EP0237737A2 (de) * 1986-01-30 1987-09-23 Enzo Biochem, Inc. Eine Zusammensetzung, spezifisch für Neisseria-Gonorrhoeae
EP0245129A1 (de) * 1986-04-04 1987-11-11 Institut Pasteur Oligonukleotid-Sonden und Verfahren zum Nachweis mittels Hybridisierung von Nukleinsäuren in Bakterien und anderen Lebewesen
EP0250662A1 (de) * 1986-06-25 1988-01-07 The Regents Of The University Of California Nachweis von Mykoplasma durch Hybridisierung von DNS
EP0272009A2 (de) * 1986-11-24 1988-06-22 James John Hogan Nukleinsäuresonden zum Nachweis und/oder zur Quantifizierung von nicht-viralen Organismen

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS/RRM *
CHEMICAL ABSTRACTS *
FEMS MICROBIOLOGY LETTERS *

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393743A2 (de) * 1989-04-17 1990-10-24 Eastman Kodak Company Diagnoseausrüstung, Primerzusammensetzung und ihre Verwendung zur Erwiderung oder zum Nachweis von Nukleinsäuren
EP0393743A3 (de) * 1989-04-17 1991-06-12 Eastman Kodak Company Diagnoseausrüstung, Primerzusammensetzung und ihre Verwendung zur Erwiderung oder zum Nachweis von Nukleinsäuren
WO1990014442A1 (en) * 1989-05-24 1990-11-29 Gene-Trak Systems Nucleic acid probes for the detection of neisseria gonorrhoeae
US5217862A (en) * 1989-05-24 1993-06-08 Amoco Corporation Method for the detection of Neisseria gonorrhoeae
US5162199A (en) * 1989-06-22 1992-11-10 Boehringer Mannheim Gmbh Neisseria-specific dna probe
EP0408077A3 (en) * 1989-07-14 1991-03-27 Boehringer Mannheim Gmbh Detection of neisseria gonorrhoeae
EP0408077A2 (de) * 1989-07-14 1991-01-16 Roche Diagnostics GmbH Neisseria gonorrhoeae-spezifische Oligonuleotid-Sonden
EP0439968A1 (de) * 1990-02-02 1991-08-07 N.V. Innogenetics S.A. Hybridisierungssonden, zum Nachweis von Stämmen von Haemophylus Ducreyi
US6656689B2 (en) 1990-04-18 2003-12-02 N.V. Innogenetics S.A. Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms
EP0452596A1 (de) * 1990-04-18 1991-10-23 N.V. Innogenetics S.A. Hibridizierungssonden aus dem Abstandsbereich zwischen den 16S- und 23S-rRNA-Genen und Nachweis von nichtviralen Mikroorganismen
WO1991016454A1 (en) * 1990-04-18 1991-10-31 N.V. Innogenetics S.A. Hybridization probes derived from the spacer region between the 16s and 23s rrna genes for the detection of non-viral microorganisms
US5536638A (en) * 1990-04-18 1996-07-16 N.V. Innogenetics S.A. Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of Neisseria gonorrhoeae
US5945282A (en) * 1990-04-18 1999-08-31 N.V. Innogenetics S.A. Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms
US6277577B1 (en) 1990-04-18 2001-08-21 N.V. Innogenetics S.A. Hybridization probes derived from the spacer region between the 16s and 23s rRNA genes for the detection of non-viral microorganisms
GB2262987A (en) * 1990-09-21 1993-07-07 Imp Cancer Res Tech Identification of organisms
WO1992005280A1 (en) * 1990-09-21 1992-04-02 Imperial Cancer Research Technology Limited Identification of organisms
US5654418A (en) * 1990-10-19 1997-08-05 Becton Dickinson And Company Nucleic acid probes useful for detecting microorganisms associated with vaginal infections
US5525717A (en) * 1990-11-09 1996-06-11 Behringwerke Ag Support-bound nucletide probe for neisseria gonorrhoeae
US5256536A (en) * 1990-11-09 1993-10-26 Syntex (U.S.A.) Inc. Nucleotide probe for Neisseria gonrrhoeae
US6020461A (en) * 1990-11-09 2000-02-01 Behringwerke Aktiengesellschaft Hexapeptides of Neisseria gonorrhoeae
EP0574852A2 (de) * 1992-06-17 1993-12-22 Roche Diagnostics GmbH Spezifischer Nachweis von Neisseria Gonorrhoeae
EP0574852A3 (en) * 1992-06-17 1994-07-13 Boehringer Mannheim Gmbh Specific detection of neisseria gonorrhoeae
US5389515A (en) * 1992-09-15 1995-02-14 Boehringer Mannheim Corporation Isolated nucleotide sequences for identifying Neisseria gonorrhoeae
EP0630971A3 (de) * 1993-06-23 1995-10-25 Hoffmann La Roche Verfahren, Reagenzien und Testkits zur Detektion von Neisseria Gonorrhoea.
EP0690929A1 (de) * 1994-01-21 1996-01-10 Amoco Corporation NUKLEINSÄUREPROBEN ZUR DETEKTION VON -i(HAEMOPHILUS INFLUENZA)
EP0690929A4 (de) * 1994-01-21 1999-03-31 Amoco Corp NUKLEINSÄUREPROBEN ZUR DETEKTION VON -i(HAEMOPHILUS INFLUENZA)
US7943346B2 (en) 1994-09-12 2011-05-17 Geneohm Sciences Canada Inc. Probes and primers for detection of bacterial pathogens and antibiotic resistance genes
US6100027A (en) * 1995-06-07 2000-08-08 Gen-Probe Incorporated Nucleic acid probes and amplification oligonucleotides for Neisseria species
EP0747489A2 (de) * 1995-06-07 1996-12-11 Gen-Probe Incorporated Nucleinsäuresonden und Amplifizierungsoligonukleotide für Neisseria Spezies
EP0747489A3 (de) * 1995-06-07 1997-05-21 Gen Probe Inc Nucleinsäuresonden und Amplifizierungsoligonukleotide für Neisseria Spezies
AU734526B2 (en) * 1995-06-07 2001-06-14 Gen-Probe Incorporated Nucleic acid probes and amplification oligonucleotides for neisseria species
WO1996041017A3 (en) * 1995-06-07 1997-05-15 Gen Probe Inc Nucleic acid probes and amplification oligonucleotides for neisseria species
US6541201B1 (en) 1995-06-07 2003-04-01 Gen-Probe Incorporated Hybridization assay probes and methods for detecting the presence of neisseria meningitiidis subtypes A, C and L in a sample
WO1996041017A2 (en) * 1995-06-07 1996-12-19 Gen-Probe Incorporated Nucleic acid probes and amplification oligonucleotides for neisseria species
FR2751000A1 (fr) * 1996-07-12 1998-01-16 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
WO1998002547A3 (fr) * 1996-07-12 1998-04-09 Inst Nat Sante Rech Med Adn et proteines ou peptides specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
US8357791B2 (en) 1996-07-12 2013-01-22 Institut National De La Sante Et De La Recherche Medicale (Inserm) DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof
US7029845B2 (en) 1996-07-12 2006-04-18 Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M.) DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses
US7368556B2 (en) 1996-07-12 2008-05-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof
US8426137B2 (en) 1996-11-04 2013-04-23 Genohm Sciences Canada, Inc. Methods and probes for detecting a vancomycin resistance gene
EP2128268A1 (de) 1996-11-04 2009-12-02 Geneohm Sciences Canada Inc. Artenspezifische, geschlechtsspezifische Universal-DNA-Sonden und Amplifikationsprimer zur schnellen Detektion und Identifizierung von herkömmlichen bakteriellen und fungiziden Pathogenen und zugehörige antibiotika-resistente Gene aus klinischen Proben zur Diagnosen in mikrobiologischen Laboratorien
EP2336364A1 (de) 1996-11-04 2011-06-22 Geneohm Sciences Canada Inc. Artenspezifische, geschlechtsspezifische Universal-DNA-Sonden und Amplifikationsprimer zur schnellen Detektion und Identifizierung von herkömmlichen bakteriellen und fungiziden Pathogenen und zugehörige antibiotika-resistente Gene aus klinischen Proben zur Diagnosen in mikrobiologischen Laboratorien
EP2336365A1 (de) 1996-11-04 2011-06-22 Geneohm Sciences Canada Inc. Artenspezifische, geschlechtsspezifische Universal-DNA-Sonden und Amplifikationsprimer zur schnellen Detektion und Identifizierung von herkömmlichen bakteriellen und fungiziden Pathogenen und zugehörige antibiotika-resistente Gene aus klinischen Proben zur Diagnosen in mikrobiologischen Laboratorien
EP2336366A1 (de) 1996-11-04 2011-06-22 Geneohm Sciences Canada Inc. Artenspezifische, geschlechtsspezifische Universal-DNA-Sonden und Amplifikationsprimer zur schnellen Detektion und Identifizierung von herkömmlichen bakteriellen und fungiziden Pathogenen und zugehörige antibiotika-resistente Gene aus klinischen Proben zur Diagnosen in mikrobiologischen Laboratorien
EP2339033A1 (de) 1996-11-04 2011-06-29 Geneohm Sciences Canada, Inc. Artenspezifische, geschlechtsspezifische Universal-DNA-Sonden und Amplifikationsprimer zur schnellen Detektion und Identifizierung von herkömmlichen bakteriellen und fungiziden Pathogenen und zugehörige antibiotika-resistente Gene aus klinischen Proben zur Diagnosen in mikrobiologischen Laboratorien
EP2339034A1 (de) 1996-11-04 2011-06-29 Geneohm Sciences Canada Inc. Artenspezifische, geschlechtsspezifische Universal-DNA-Sonden und Amplifikationsprimer zur schnellen Detektion und Identifizierung von herkömmlichen bakteriellen und fungiziden Pathogenen und zugehörige antibiotika-resistente Gene aus klinischen Proben zur Diagnosen in mikrobiologischen Laboratorien
EP2345746A1 (de) 1996-11-04 2011-07-20 Geneohm Sciences Canada Inc. Artenspezifische, geschlechtsspezifische Universal-DNA-Sonden und Amplifikationsprimer zur schnellen Detektion und Identifizierung von herkömmlichen bakteriellen und fungiziden Pathogenen und zugehörige antibiotika-resistente Gene aus klinischen Proben zur Diagnosen in mikrobiologischen Laboratorien
EP1254254B1 (de) * 1999-09-24 2011-11-09 Biotecon Diagnostics GmbH Nukleinsäuremoleküle zum nachweis von bakterien und phylogenetischen einheiten von bakterien
US8182996B2 (en) 1999-09-28 2012-05-22 Geneohm Sciences Canada Inc. Compositions and methods for detecting Klebsiella pneumoniae
US8114601B2 (en) 1999-09-28 2012-02-14 Geneohm Sciences Canada Inc. Highly conserved genes and their use to generate probes and primers for detection of microorganisms
WO2001023604A2 (en) 1999-09-28 2001-04-05 Infectio Diagnostic (I.D.I.) Inc. Highly conserved genes and their use to generate probes and primers for detection of microorganisms
EP2660335A2 (de) 1999-09-28 2013-11-06 Geneohm Sciences Canada, Inc. Hoch konservierte Gene und ihre Verwendung zum Erzeugung von artenspezifischen, geschlechtsspezifischen, familienspezifischen, gruppenspezifischen und Universalnukleinsäuresonden und Verstärkungsprimer zum Schnellnachweis und Identifizieren von Algen-, Archaea-, Bakterien-, Pilz- und Parasitenmikroorganismen aus klinischen Proben zur Diagnose
US10047404B2 (en) 1999-09-28 2018-08-14 Geneohm Sciences Canada, Inc. Highly conserved tuf genes and their use to generate probes and primers for detection of coagulase-negative Staphylococcus
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
US8580495B2 (en) 2002-11-12 2013-11-12 Abbott Laboratories Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
US9187789B2 (en) 2002-11-12 2015-11-17 Abbott Molecular Inc. Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae
KR100532665B1 (ko) * 2002-11-28 2005-12-02 주식회사 바이오메드랩 나이세리아속 균 탐지용 프로브, 이를 이용한나이세리아속 균의 유전형 분석키트 및 유전형 분석방법
US9139866B2 (en) 2006-02-17 2015-09-22 Morinaga Milk Industry Co., Ltd. Method for detection of microorganism and kit for detection of microorganism
US9567625B2 (en) 2006-02-17 2017-02-14 Morinaga Milk Industry Co., Ltd. Method for detection of microorganism and kit for detection of microorganism
CN105199948A (zh) * 2015-09-29 2015-12-30 窦晓鸣 大肠杆菌的快速检验试剂盒及检测方法

Also Published As

Publication number Publication date
DE68907772D1 (de) 1993-09-02
DE68907772T2 (de) 1993-11-04
ES2058566T3 (es) 1994-11-01
EP0337896B1 (de) 1993-07-28
AU3300489A (en) 1989-10-19
CA1339261C (en) 1997-08-12
JPH02203800A (ja) 1990-08-13
AU615286B2 (en) 1991-09-26

Similar Documents

Publication Publication Date Title
EP0337896B1 (de) Hybridisationssonden zum Nachweis von Neisseria-Stämme
EP0525095B2 (de) Hybridizierungssonden von dem abstand zwischen den 16s und 23s rna genen und nachweis von nicht-viralen mikroorganismen
US5536638A (en) Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of Neisseria gonorrhoeae
WO2001023608A2 (en) Hybridization probes which specifically detect strains of the genera microbispora, microtetraspora, nonomuria and planobispora
EP0630971A2 (de) Verfahren, Reagenzien und Testkits zur Detektion von Neisseria Gonorrhoea
EP0709467A2 (de) Zusammensetzungen und Verfahren für die Detektion von Chlamydia Trachomatis
EP0556504B1 (de) Oligonucleotide zum Nachweis von Vibrio parahaemolyticus
EP0581171A1 (de) Spezies-Spezifische Oligonukleotide gegen Bifidobakterien und Verfahren zum Nachweis unter Verwendung derselben
WO2007114506A1 (en) Probe, probe set, probe-immobilized carrier, and genetic testing method
WO2007114504A1 (en) Probe, probe set, probe-immobilized carrier, and genetic testing method
EP0426843B1 (de) Nukleinsäuresonden für die detektion von neisseria gonorrhoeae
EP1560929B1 (de) Polynukleotide zur amplifikation undzum nachweis von chlamydia trachomatis und neisseria gonorrhoeae
WO1991011531A1 (en) Hybridization probes for the detection of branhamella catarrhalis strains
EP0808907A2 (de) Zusammensetzungen und Verfahren für den Nachweis von Mycobacterium kansasii
CA2150986C (en) Oligonucleotide primers and probes for detection of bacteria
EP1273668A1 (de) Nukleinsäureprimer eines säureresistenten bakteriums und methoden zur identifizierung eines säureresistenten bakteriums
EP0554437B1 (de) Nukleinsäure sonden welche bei nachweis von shigellabakterien verwendbar sind
US5721097A (en) Hybridization probes for the detection of branhamella catarrhalis strains
WO2006116010A2 (en) Detection of virulence markers of staphylococci
EP0747489A2 (de) Nucleinsäuresonden und Amplifizierungsoligonukleotide für Neisseria Spezies
EP0439968A1 (de) Hybridisierungssonden, zum Nachweis von Stämmen von Haemophylus Ducreyi
WO1999014361A1 (en) Hybridization probes which differentiate between streptomycetes and maduromycetes
JPH07114719B2 (ja) 細菌検出のためのオリゴヌクレオチドおよびそれを用いた検出法
WO2001023609A2 (en) Hybridization probes which detect bacteria of the genus thermobifida
WO2007114516A1 (en) Probe, probe set, probe-immobilized carrier, and genetic testing method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

17P Request for examination filed

Effective date: 19900129

17Q First examination report despatched

Effective date: 19910725

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

REF Corresponds to:

Ref document number: 92111

Country of ref document: AT

Date of ref document: 19930815

Kind code of ref document: T

REF Corresponds to:

Ref document number: 68907772

Country of ref document: DE

Date of ref document: 19930902

ET Fr: translation filed
ITF It: translation for a ep patent filed

Owner name: ING. A. GIAMBROCONO & C

REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3009470

EPTA Lu: last paid annual fee
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2058566

Country of ref document: ES

Kind code of ref document: T3

EAL Se: european patent in force in sweden

Ref document number: 89401045.3

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20010215

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20010315

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20010319

Year of fee payment: 13

Ref country code: AT

Payment date: 20010319

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20010321

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20010329

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20010402

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20010406

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20010409

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20010412

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20010418

Year of fee payment: 13

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020414

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020414

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020415

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020415

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020430

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021101

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021105

EUG Se: european patent has lapsed

Ref document number: 89401045.3

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20020414

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20021231

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20021101

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20030514

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050414